Lung Cancer Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Oncology physicians who work at a participating site and have no plans to leave or retire at the time of enrolling in the study.
• People aged 60 or older who have been diagnosed with non-small cell lung cancer that cannot be removed by surgery, and who are being treated at a participating site.
• People whose cancer has been staged using scans rather than surgical confirmation of lymph node involvement.
• People who are planning to start a new cancer treatment within 4 to 6 weeks of their first study visit, where that treatment includes chemotherapy or a drug with a similar level of side effects — this may be given alongside or separately from radiation therapy.
• People receiving approved cancer treatment — including certain targeted therapies or monoclonal antibodies — either combined with or separately from radiation therapy, including a specific type of radiation given in larger daily doses over a shorter period (confirm with trial site for specific radiation details).
• People whose cancer has spread to only one area outside the radiation treatment zone, such as a single spot in the brain, a nodule in the opposite lung, or a single adrenal gland lesion.
• People who are already taking part in another treatment trial may also be eligible for this study, provided all other criteria are met.
• People who are able to give their own consent, or — if the treating doctor determines the person lacks the capacity to make decisions — a legally designated healthcare representative may provide consent on their behalf before the first study visit.
• People with a sufficient understanding of English to complete the study assessments; those who prefer Spanish or Mandarin should be discussed with the study team, as inclusion will depend on the availability of qualified translators (confirm with trial site).

Who may not be able to join:

• People who have surgery planned within 3 months of being approached for the study (people who have already had surgery in the past may still be eligible).
• People who have cancer that has spread to the brain in more than one spot and where those spots are causing symptoms at the time of consent; people with a history of treated brain metastases, or very small brain lesions under 1 cm that are not causing symptoms, may still be eligible.
• People whose cancer has spread to more than one area of the body outside the main tumour — for example, both the brain and the adrenal gland, or both the adrenal gland and the liver.

Important: Always verify eligibility with the trial site directly before applying.